Desloratadine for chronic idiopathic urticaria : A review of clinical efficacy
作者： Lawrence DuBuske
DOI: 10.2165/00128071-200708050-00002
关键词: Quality of life 、 Histamine 、 Dermatology 、 Pharmacotherapy 、 Medicine 、 Clinical efficacy 、 Histamine H1 Antagonists 、 Chronic disease 、 Desloratadine 、 Chronic idiopathic urticaria
摘要: Chronic idiopathic urticaria (CIU) is a disabling affliction that considerably limits patients’ daily activities and interferes with sleep. Clinical studies have shown histamine H1-receptor antagonists (antihistamines) are highly effective for inhibiting the hives/wheals pruritus associated CIU, as well improving quality of life.
springer.com
sci-hub.se 参考文章(80)
Antihistamines in urticaria and angioedema. Clinical allergy and immunology. ,vol. 17, pp. 249- 286 ,(2002) , 10.3109/9780203910375-13
William Kreutner, John Hey, John Anthes, Allen Barnett, Simon Young, Salvatore Tozzi, Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects. Drug Research. ,vol. 50, pp. 345- 352 ,(2011) , 10.1055/S-0031-1300213
Lawrence M. DuBuske, Pharmacology of Desloratadine Special Characteristics Clinical Drug Investigation. ,vol. 22, pp. 1- 11 ,(2002) , 10.2165/00044011-200222002-00001
F. Estelle R. Simons, Advances in H1-Antihistamines The New England Journal of Medicine. ,vol. 351, pp. 2203- 2217 ,(2004) , 10.1056/NEJMRA033121
Alison D F Handford, Barbara M Stone, Claire Turner, Anthony N Nicholson, Studies on performance and sleepiness with the H1-antihistamine, desloratadine. Aviation, Space, and Environmental Medicine. ,vol. 74, pp. 809- 815 ,(2003)
Joint Task Force on Practice Parameters, The diagnosis and management of urticaria: a practice parameter part I: acute urticaria/angioedema part II: chronic urticaria/angioedema. Joint Task Force on Practice Parameters. Annals of Allergy Asthma & Immunology. ,vol. 85, pp. 521- 544 ,(2000)
R. D Mann, Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice Commentary: Reporting of adverse events is worth the effort BMJ. ,vol. 320, pp. 1184- 1187 ,(2000) , 10.1136/BMJ.320.7243.1184
Radoslaw Spiewak, Inter- and intra-individual variability of skin reactivity to histamine at prick-testing. Dermatology Online Journal. ,vol. 1, ,(1995)
Ashok Purohit, Michel Melac, Gabrielle Pauli, Nelly Frossard, Twenty-four-hour activity and consistency of activity of levocetirizine and desloratadine in the skin British Journal of Clinical Pharmacology. ,vol. 56, pp. 388- 394 ,(2003) , 10.1046/J.1365-2125.2003.01897.X
JJ Grob, P Auquier, I Dreyfus, JP Ortonne, Quality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double-blind, multicentre, placebo-controlled study. Journal of The European Academy of Dermatology and Venereology. ,vol. 22, pp. 87- 93 ,(2007) , 10.1111/J.1468-3083.2007.02385.X